Cargando…
Hemolytic Anemia in Inflammatory Bowel Disease: Our “Gut” Tells Us to Blame the Drug
BACKGROUND: Several studies determined that autoimmune hemolytic anemia (AIHA) is a rare extraintestinal IBD manifestation, related to the underlying disease activity. However, evidence linking biologic therapy to AIHA is sparse. METHODS: This article reviews the evidence on the association of these...
Autores principales: | Berger, Matthew, Abdalla, Maisa, DeCross, Arthur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802309/ https://www.ncbi.nlm.nih.gov/pubmed/36777271 http://dx.doi.org/10.1093/crocol/otab070 |
Ejemplares similares
-
Cannabis in Gastroenterology: Watch Your Head! A Review of Use in Inflammatory Bowel Disease, Functional Gut Disorders, and Gut-Related Adverse Effects
por: Nasser, Yasmin, et al.
Publicado: (2020) -
In vivo transplantation of fetal human gut‐derived enteric neural crest cells
por: Cooper, J. E., et al.
Publicado: (2016) -
„Verankerung“ von Klassifikationskriterien für axiale Spondyloarthritis – wie weit ist gut für die Diagnosestellung?
por: Braun, J., et al.
Publicado: (2020) -
Impact of Diet on Inflammatory Bowel Disease Symptoms: An Adolescent Viewpoint
por: Zangara, Megan T, et al.
Publicado: (2020) -
Palliative Care in Inflammatory Bowel Disease: A New Partnership
por: Rivet, Emily B, et al.
Publicado: (2021)